Sharenet Sites 
Sharenet Sites
GEN - FTSE/JSE Africa Index Series - Aspen Pharmacare Holdings (South Africa): Shares in Issue Update Aspen Pharmacare Holdings (South Africa): Shares in Issue Update FTSE/JSE Africa Index Series 10 December 2009 Following the receipt of updated shares in issue information for Aspen Pharmacare Holdings (South Africa, constituent) and notification from the Stock Exchange, FTSE and the JSE announces the following changes: INDEX CHANGE EFFECTIVE FROM START OF TRADING FTSE/JSE Africa Top 40 Aspen Pharmacare Holdings 21 December 2009 (J200) (South Africa, ZAE000066692, B09C0Z1) will remain in the index with an increased shares in issue total of 431,451,704 and an unchanged investability
weighting of 100%. FTSE/JSE Africa All Share Aspen Pharmacare Holdings will 21 December 2009 (J203) remain in the index as detailed above.
FTSE/JSE Africa Industrial Aspen Pharmacare Holdings will 21 December 2009 25 (J211) remain in the index as detailed above. FTSE/JSE Africa Financial & Aspen Pharmacare Holdings will 21 December 2009 Industrial 30 (J213) remain in the index as detailed above. FTSE/JSE Africa Financial & Aspen Pharmacare Holdings will 21 December 2009 Industrial (J250) remain in the index as detailed above. FTSE/JSE Africa All Share Aspen Pharmacare Holdings will 21 December 2009 Industrials (J257) remain in the index as detailed above.
FTSE/JSE Africa Capped Top Aspen Pharmacare Holdings will 21 December 2009 40 (J300) remain in the index as detailed above. FTSE/JSE Africa Capped All Aspen Pharmacare Holdings will 21 December 2009 Share (J303) remain in the index as detailed above. FTSE/JSE Africa Style (J330 Aspen Pharmacare Holdings will 21 December 2009 and J331) remain in the index as detailed above. FTSE/JSE Africa Shareholder Aspen Pharmacare Holdings 21 December 2009 Weighted Top 40 (J400) (South Africa, ZAE000066692, B09C0Z1) will remain in the
index with an increased shares in issue total of 431,451,704 and an unchanged investability weighting of 75%.
FTSE/JSE Africa Shareholder Aspen Pharmacare Holdings will 21 December 2009 Weighted All Share (J403) remain in the index as detailed above. FREE TRIAL OFFER: FTSE offers free one month index trials to interested clients. For further information or general enquiries please contact us at info@ftse.com or indices@jse.co.za or call: Client Services in UK: Tel: +44 (0) 20 7866 1810 Client Services in Europe, Middle East & Africa: Tel: +44 (0) 20 7866 1810 Client Services in US: Tel: +1 888 747 FTSE (3873) or +1 212 314 1139 Client Services in Asia Pacific: Tel: +852 2230 5803 or +65 6223 3738
or +81 3 3581 2811 JSE Limited: Tel: (+27 11) 520 7106 or +520 7137 Alternatively please visit our website at www.ftse.com or www.ftsejse.co.za Terms of Use | Copyright Copyright FTSE Date: 11/12/2009 07:05:11 Supplied by www.sharenet.co.za Produced by the JSE SENS Department.
